Galmed Pharmaceuticals Ltd.
GLMD
$1.07
$0.1111.59%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 19.05M | 20.53M | 15.73M | 15.33M | 17.14M |
| Total Receivables | 549.00K | 433.00K | 447.00K | 209.00K | 426.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | 463.00K | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 124.00K | 123.00K | 122.00K | 121.00K | 119.00K |
| Total Current Assets | 19.72M | 21.08M | 16.30M | 16.12M | 17.69M |
|
|
|||||
| Total Current Assets | 19.72M | 21.08M | 16.30M | 16.12M | 17.69M |
| Net Property, Plant & Equipment | -- | -- | -- | 0.00 | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 267.00K | 267.00K | 267.00K | 257.00K | -- |
| Total Assets | 21.58M | 22.94M | 18.68M | 18.50M | 20.95M |
|
|
|||||
| Total Accounts Payable | 1.67M | 1.37M | 1.31M | 1.31M | 1.34M |
| Total Accrued Expenses | -- | -- | -- | 859.00K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 798.00K | 1.05M | 499.00K | 6.00K | 1.17M |
| Total Other Current Liabilities | 798.00K | 1.05M | 499.00K | 6.00K | 1.17M |
| Total Current Liabilities | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M |
|
|
|||||
| Total Current Liabilities | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 2.47M | 2.42M | 1.81M | 2.17M | 2.51M |
|
|
|||||
| Common Stock & APIC | 225.39M | 224.99M | 218.85M | 217.21M | 216.04M |
| Retained Earnings | -205.96M | -204.07M | -201.57M | -200.47M | -197.26M |
| Treasury Stock & Other | -316.00K | -403.00K | -397.00K | -416.00K | -342.00K |
| Total Common Equity | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 19.11M | 20.52M | 16.88M | 16.33M | 18.44M |
|
|
|||||